Holen Sie sich die Stockscreener-App
161.93
1.79%
2.84
Handel nachbörslich:
161.94
0.010
+0.01%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Ovarian Cancer Diagnostics Market Size to Reach USD 8.08 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
Why Illumina’s NovaSeq X Plus is quietly reshaping high-throughput genomics - AD HOC NEWS
IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist - Business Wire
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Video: Professor Emma Baple on bringing whole-genome sequencing into clinical research - Illumina
Illumina Inc (ILMN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Illumina StockCasdin Capital and Gotham build positions as consensus stays cautious - AD HOC NEWS
Illumina Inc (ILMN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Illumina Inc (ILMN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Illumina Inc (ILMN) Shares Fall 3.2% -- GF Value Says Still Over - GuruFocus
Illumina Inc (ILMN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Illumina Connected Analytics brings clinical-grade genomics to the cloud for hospitals and labs - AD HOC NEWS
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Illumina Inc. Stock (US4523271090): Quarterly earnings and strategic reset in focus - AD HOC NEWS
Illumina Inc (ILMN) Institutional Confidence - TradingKey
New spatial twist, Illumina StrataMap Spatial Solution targets multi-omics labs - AD HOC NEWS
Is Illumina Inc (ILMN) Overvalued After 3.7% Rally? GF Value Say - GuruFocus
Illumina Inc. Stock (US4523271090): Analyst sentiment leans bullish after strong 12-month rebound - AD HOC NEWS
Illumina, Inc. (ILMN): Investor Outlook On A Genomic Pioneer With A 33.82% ROE - DirectorsTalk Interviews
What is proteomics? A simple guide to understanding measuring proteins at scale - Illumina
Illumina raised to overweight at JP Morgan after customer survey - MSN
Illumina Inc. Stock (US4523271090): shares steady as investors await next earnings catalyst - AD HOC NEWS
Liquidity Mapping Around (ILMN) Price Events - Stock Traders Daily
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
Illumina Inc (ILMN) Stock Down 3.1% but Still Overvalued -- GF S - GuruFocus
When sequencing isn’t enough: A global forum for finding answers - Illumina
Illumina Stock’s Operating Margin Climbs to 22% in Q1 2026: Is it Enough to Support a $300 Target? - TIKR.com
Fox Run Management L.L.C. Makes New Investment in Illumina, Inc. $ILMN - MarketBeat
Loomis Sayles Growth Portfolio's Illumina Inc(ILMN) Holding History - GuruFocus
Illumina stock upgraded at J.P. Morgan (ILMN:NASDAQ) - Seeking Alpha
Illumina (NASDAQ:ILMN) Shares Gap Up After Analyst Upgrade - MarketBeat
JPMorgan Upgrades Illumina to Overweight From Neutral, Price Target is $185 - marketscreener.com
Amova Asset Management Americas Inc. Reduces Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Insider Sell: Patricia Leckman Sells Shares of Illumina Inc (ILM - GuruFocus
Illumina SVP Patricia Leckman sells $127,304 in company stock By Investing.com - Investing.com Australia
Illumina SVP Patricia Leckman sells $127,304 in company stock - Investing.com UK
Illumina Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Illumina (ILMN): Bullish Structure Builds After Breakout - FXEmpire
Illumina (ILMN) Chief People Officer sells 783 common shares - Stock Titan
Illumina Inc. stock (US4523271090): new StrataMap launch after strong 12?month rally - AD HOC NEWS
Templeton Global Smaller Companies Fund's Illumina Inc(ILMN) Holding History - GuruFocus
Illumina Inc. stock underperforms Monday when compared to competitors - MarketWatch
Illumina launches StrataMap Spatial Solution, a powerful end-to- - GuruFocus
8 Cancer organizations receive grants to expand access to genomic testing - Illumina
Illumina Launches StrataMap Spatial Solution for Whole Transcriptome Analysis - geneonline.com
Illumina launches StrataMap Spatial research solution By Investing.com - Investing.com Canada
Illumina launches StrataMap Spatial research solution - Investing.com
Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution - Illumina
Capital International Inc. CA Boosts Stock Position in Illumina, Inc. $ILMN - MarketBeat
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
Illumina (ILMN) Valuation Check After New Oncology Collaborations And MRD Research Launch - Yahoo Finance
Illumina, Inc. $ILMN Shares Sold by Capital International Ltd. CA - MarketBeat
Capital World Investors Boosts Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Capital International Sarl Sells 15,683 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. $ILMN Shares Sold by Bank of New York Mellon Corp - MarketBeat
Illumina (Nasdaq: ILMN) Form 144 lists proposed sale by trust - Stock Titan
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Illumina (ILMN) chief people officer sells 784 shares in open market - Stock Titan
What is multiomics? A simple guide to the future of biology - Illumina
1.36%
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):